Medicare AdvancePrior AuthHigh impact
Orencia (abatacept) Subcutaneous (Revised)
Humana·Rheumatology, Internal Medicine·Medicare Advantage
We identified it
Jul 22, 2026
Summary
This is a revised Prior Authorization policy for Orencia (abatacept) Subcutaneous for Medicare Advantage members. The policy update affects how prior authorization requests must be submitted and approved before dispensing this biologic medication. Billing teams must implement the new requirements immediately to avoid claim denials.
Action Required
Immediately: Billing team must update prior authorization workflows in all systems to reflect the revised Orencia (abatacept) subcutaneous policy requirements for Medicare Advantage members. Before submitting claims for HCPCS code J7214, verify that current prior authorization has been obtained from Humana and documented in the patient record. Update provider templates and encounter documentation to include PA requirement reminders. Communicate policy revision to all providers who prescribe Orencia. Claims submitted without current prior authorization will be denied. Reference the complete policy at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a58683a for specific approval criteria and documentation requirements.